Clinical Studies

Johns Hopkins University & University of Maryland at College Park

Johns Hopkins University and the University of Maryland at College Park are conducting a clinical trial to test a new herpes vaccine. The vaccine is for women who do not already have oral or genital herpes, and is intended to reduce the risk that they will acquire the disease. This is a Stage III trial, the final testing stage before seeking FDA approval. The trial involves several thousand participants at 20 medical institutions.

For details, go to or call:
Karen at Johns Hopkins (410) 955-2530
Pam Welch or Jan Cowan at University of Maryland (301) 314-7575

SNBL Clinical Pharmacology Center

SNBL Clinical Pharmacology Center (Baltimore, MD) is conducting a research study with an investigational medication to see if it helps to reduce the healing time for genital herpes outbreaks.

To qualify, participants must be medically diagnosed with genital herpes, be at least 18 years of age, and be in good general health.

Qualified participants will receive: Study Medication, Physical Exams, Laboratory Tests, and you may also be compensated for your time and travel.

Call (410)-706-8833 or email